Presentation is loading. Please wait.

Presentation is loading. Please wait.

EVEREST II randomized clinical trial: Predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure  Donald Glower, MD, Gorav.

Similar presentations


Presentation on theme: "EVEREST II randomized clinical trial: Predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure  Donald Glower, MD, Gorav."— Presentation transcript:

1 EVEREST II randomized clinical trial: Predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure  Donald Glower, MD, Gorav Ailawadi, MD, Michael Argenziano, MD, Michael Mack, MD, Alfredo Trento, MD, Andrew Wang, MD, D. Scott Lim, MD, William Gray, MD, Paul Grayburn, MD, John Dent, MD, Linda Gillam, MD, Barathi Sethuraman, MD, Ted Feldman, MD, Elyse Foster, MD, Laura Mauri, MD, Irving Kron, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 143, Issue 4, Pages S60-S63 (April 2012) DOI: /j.jtcvs Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Type of procedure (percutaneous or surgical) performed through 1 year for MitraClip and surgery groups. The Journal of Thoracic and Cardiovascular Surgery  , S60-S63DOI: ( /j.jtcvs ) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "EVEREST II randomized clinical trial: Predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure  Donald Glower, MD, Gorav."

Similar presentations


Ads by Google